Panax ginseng has a reasonable literature on glucose markers — but almost all of it uses root extract. When a label specifies aerial extract instead, that is a meaningful difference most buyers never notice.
Panax ginseng — Asian, Korean or red ginseng — is one of the most studied botanicals in the world. Its active constituents are ginsenosides, a large family of triterpene saponins with varied and sometimes opposing activities.
It should be distinguished from American ginseng (Panax quinquefolius), which has a different ginsenoside profile, and from Siberian ginseng (Eleutherococcus senticosus), which is not a ginseng at all and belongs to a different genus entirely. All three appear in supplements, sometimes in the same product.
There is a genuine body of research on Panax ginseng and glucose markers, including randomised trials and meta-analyses looking at fasting glucose and insulin sensitivity. Findings generally suggest modest reductions in fasting glucose, with considerable heterogeneity between studies.
The variability is not surprising given how much ginseng preparations differ — species, plant part, age at harvest, processing method (red versus white ginseng involves steaming, which changes the ginsenoside profile) and standardisation all vary between products and studies.
This is the detail worth taking away.
The overwhelming majority of ginseng research — traditional use, clinical trials, standardisation conventions — uses the root. When a supplement label specifies aerial extract, it means the above-ground parts: leaves and stems.
Aerial parts do contain ginsenosides, and in some cases at higher total concentration than root. But the profile of individual ginsenosides differs, and since different ginsenosides have different and sometimes opposing effects, a higher total does not mean equivalent activity.
Aerial material is also considerably cheaper. Ginseng root takes four to six years to reach harvestable maturity; leaves and stems are available annually as a by-product.
This does not make aerial extract worthless. It does mean that research conducted on root cannot simply be transferred to a product using aerial extract, and a label specifying "aerial" is worth noticing.
Trials typically use 200–400 mg daily of standardised root extract, sometimes higher, over periods of eight to twelve weeks. Standardisation is usually to total ginsenoside content.
Inside a small proprietary blend, reaching that range is not realistic.
Panax ginseng is generally well tolerated but has more documented interactions than most botanicals:
Stop before scheduled surgery given the glucose and bleeding considerations.
Panax ginseng has real, if modest, evidence for glucose markers at research dosages using root extract. It is a defensible ingredient in a blood sugar formula when properly dosed and properly sourced.
Two things to check on any label: the plant part, and the amount. A product specifying aerial extract inside an undisclosed blend is a long way from the conditions under which the supporting research was conducted.
Our full analysis covers the proprietary blend, the hidden caffeine and who should skip it.
Read Our Review Check PriceDisclaimer: general information, not medical advice. Do not change prescribed medication based on anything here. If you take glucose-lowering medication, speak to your doctor or pharmacist before starting any supplement. See our full disclaimer.